[
  {
    "ts": null,
    "headline": "Acadia Healthcare Q4 Earnings Beat Estimates on Rising Admissions",
    "summary": "ACHC tops Q4 estimates as admissions and patient days rise, lifting revenues, but profit plunges 89% year over year.",
    "url": "https://finnhub.io/api/news?id=c2e217ddd2c218d85aeb7f96a75294039f9e7459abe71ef4334af6584957531c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772039640,
      "headline": "Acadia Healthcare Q4 Earnings Beat Estimates on Rising Admissions",
      "id": 139223967,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "ACHC tops Q4 estimates as admissions and patient days rise, lifting revenues, but profit plunges 89% year over year.",
      "url": "https://finnhub.io/api/news?id=c2e217ddd2c218d85aeb7f96a75294039f9e7459abe71ef4334af6584957531c"
    }
  },
  {
    "ts": null,
    "headline": "UnitedHealth Group Board Authorizes Payment of Quarterly Dividend",
    "summary": "February 25, 2026--UNH Quarterly Dividend Announcement",
    "url": "https://finnhub.io/api/news?id=73274b58dc9627d127d8c969bd239ac9a95db7934dac05cc0d0509af7a7a3476",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772020200,
      "headline": "UnitedHealth Group Board Authorizes Payment of Quarterly Dividend",
      "id": 139206487,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "February 25, 2026--UNH Quarterly Dividend Announcement",
      "url": "https://finnhub.io/api/news?id=73274b58dc9627d127d8c969bd239ac9a95db7934dac05cc0d0509af7a7a3476"
    }
  },
  {
    "ts": null,
    "headline": "These 4 charts show the scale of Novo Nordisk's woes",
    "summary": "Despite being first to launch a GLP-1 drug for weight loss, Novo's market share has eroded, and the company now only captures about 40% of the market.",
    "url": "https://finnhub.io/api/news?id=16985f75739012f9804d2c8eecc059bddaf431662a1b6197fe1e120314a3474f",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771997562,
      "headline": "These 4 charts show the scale of Novo Nordisk's woes",
      "id": 139212445,
      "image": "https://image.cnbcfm.com/api/v1/image/108245068-1766477256303-gettyimages-2228673815-raa-novonord250809_npj4Z.jpeg?v=1768247892&w=1920&h=1080",
      "related": "UNH",
      "source": "CNBC",
      "summary": "Despite being first to launch a GLP-1 drug for weight loss, Novo's market share has eroded, and the company now only captures about 40% of the market.",
      "url": "https://finnhub.io/api/news?id=16985f75739012f9804d2c8eecc059bddaf431662a1b6197fe1e120314a3474f"
    }
  }
]